DESCRIPTION TABLE OF CONTENTS METHODOLOGY DOWNLOAD PDF GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, tirzepatide), Type (Patented, Biosimilars), Format (Single dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033 USD 170.75 BN MARKET SIZE, 2033 OVERVIEW Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis The global GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period
4,5 The current findings complement the company's ongoing research into how obesity impacts individuals' daily lives, according to Novo Nordisk
We procure premium ingredients exclusively from accredited facilities, ensuring our products adhere to the highest standards of quality and safety
Is there a test for Vitamin B12 Deficiency and folate deficiency
These supplements come in the form of oral supplements and injections